Ganfeng Cao

This inventor holds 32 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Pfizer Corporation. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ganfeng Cao. Retrieved from https://idiyas.com/inventor/ganfeng-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 8)

% Patents Active = 81.3

CIPO Patents = 8 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 314(Granted Patents)

Location History:

Bear, DE (US) (2008 - 2012)
Wilmington, DE (US) (2014)
Newark, DE (US) (2007 - 2017)
Chadds Ford, PA (US) (2018 - 2024)

Company Filing History:

Incyte Holdings Corporation

Prelude Therapeutics Incorporated

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

PRMT5

JAK Inhibitors

Pim Kinase Inhibitor

LSD1 Inhibitor

Chemokine Receptor Antagonists

Piperazinylpiperidine

3-Aminopyrrolidine

Purinone Derivatives

3-Aminocyclopentanecarboxamides

Modulators

Agonists

Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12414953 - Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) (2025-09-16),

2. 12247020 - Bipyrazole derivatives as JAK inhibitors (2025-03-11),

3. 12043614 - Salts of a Pim kinase inhibitor (2024-07-23),

4. 11905275 - Bipyrazole derivatives as JAK inhibitors (2024-02-20),

5. 11591318 - Bipyrazole derivatives as JAK inhibitors (2023-02-28),

6. 11505540 - Salts of a Pim kinase inhibitor (2022-11-22),

7. 11498900 - Salts of an LSD1 inhibitor (2022-11-15),

8. 11001571 - Bipyrazole derivatives as JAK inhibitors (2021-05-11),

9. 10723700 - Salts of an LSD1 inhibitor (2020-07-28),

10. 10329255 - Salts of an LSD1 inhibitor (2019-06-25),

11. 9862705 - Salts of a pim kinase inhibitor (2018-01-09),

12. 9714233 - Processes and intermediates for making a JAK inhibitor (2017-07-25),

13. 9487521 - Processes and intermediates for making a JAK inhibitor (2016-11-08),

14. 9221845 - Processes and intermediates for making a JAK inhibitor (2015-12-29),

15. 9067921 - Piperazinylpiperidine derivatives as chemokine receptor antagonists (2015-06-30),

Title: Ganfeng Cao: Pioneering Inventor from Newark, DE

Introduction: Ganfeng Cao is a distinguished inventor based in Newark, DE, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ganfeng Cao holds several patents in the areas of renewable energy, artificial intelligence, and biotechnology, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Ganfeng Cao has worked with leading research institutions and companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Ganfeng Cao has collaborated with top scientists, engineers, and inventors globally, fostering a culture of creativity and excellence in his projects.

Conclusion: Ganfeng Cao's relentless pursuit of innovation and his remarkable contributions have solidified his position as a trailblazing inventor in the technological landscape.

Profile summary based on public USPTO records.